SUNPHARMA / FY26 summary

The year in one view.

Sunpharma · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

1,44,708.6

₹ Cr where applicable

PAT across quarters

29,344.6

₹ Cr where applicable

Source quarters

11

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
11 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 3,308 · Watch source sentiment · 2023-08-10Q1 FY24Q2 FY24: 3,179.4 · Watch source sentiment · 2023-11-15Q2 FY24Q3 FY24: 3,476.8 · Positive source sentiment · 2024-01-23Q3 FY24Q4 FY24: 3,035.2 · Watch source sentiment · 2024-05-15Q4 FY24Q1 FY25: 3,607.6 · Positive source sentiment · 2024-08-01Q1 FY25Q2 FY25: 3,939 · Positive source sentiment · 2024-11-14Q2 FY25Q3 FY25: 4,009 · Positive source sentiment · 2025-02-13Q3 FY25Q4 FY25: 3,716.1 · Watch source sentiment · 2025-05-15Q4 FY25Q1 FY26: 4,301.7 · Positive source sentiment · 2025-08-01Q1 FY26Q2 FY26: 4,527.1 · Positive source sentiment · 2025-11-14Q2 FY26Q3 FY26: 4,948.5 · Positive source sentiment · 2026-02-07Q3 FY264,948.53,035.2
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.